Sanara MedTech Inc.
SMTI
$20.76
$0.391.92%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 30.55% | 34.29% | 34.65% | 33.36% | 24.66% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 30.55% | 34.29% | 34.65% | 33.36% | 24.66% |
| Cost of Revenue | 2.82% | 7.73% | 6.14% | 3.66% | -8.95% |
| Gross Profit | 33.58% | 37.33% | 38.25% | 37.45% | 29.89% |
| SG&A Expenses | 23.02% | 25.92% | 32.37% | 30.65% | 25.56% |
| Depreciation & Amortization | -1.29% | -6.19% | 0.67% | 9.10% | 17.91% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 22.00% | 23.86% | 28.47% | 26.27% | 18.37% |
| Operating Income | 91.16% | 67.52% | 26.89% | 33.87% | 29.01% |
| Income Before Tax | -11.10% | -11.09% | -77.95% | -62.38% | 30.81% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -11.10% | -11.09% | -77.95% | -62.38% | 30.81% |
| Earnings from Discontinued Operations | -1,066.35% | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 91.96% | 39.92% | 41.97% | 63.72% | -48.06% |
| Net Income | -348.29% | -51.36% | -133.72% | -124.59% | -2.33% |
| EBIT | 91.16% | 67.52% | 26.89% | 33.87% | 29.01% |
| EBITDA | 333.94% | 144.42% | 68.92% | 83.64% | 69.70% |
| EPS Basic | -339.97% | -49.09% | -128.37% | -118.26% | 1.25% |
| Normalized Basic EPS | 11.28% | 15.49% | -16.03% | 2.44% | 6.43% |
| EPS Diluted | -328.60% | -49.09% | -128.37% | -118.26% | 1.25% |
| Normalized Diluted EPS | 10.94% | 15.49% | -16.03% | 2.44% | 6.43% |
| Average Basic Shares Outstanding | 1.70% | 1.87% | 2.18% | 2.48% | 2.86% |
| Average Diluted Shares Outstanding | 2.57% | 1.87% | 2.18% | 2.48% | 2.86% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |